Cystic fibrosis natural history, complications and prognosis: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cystic fibrosis}} | {{Cystic fibrosis}} | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}}, {{SHH}} | ||
==Overview== | ==Overview== | ||
| Line 13: | Line 13: | ||
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%. | Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%. | ||
==Natural History== | ==Natural History== | ||
Revision as of 14:15, 9 February 2018
|
Cystic fibrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cystic fibrosis natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Cystic fibrosis natural history, complications and prognosis |
|
FDA on Cystic fibrosis natural history, complications and prognosis |
|
CDC on Cystic fibrosis natural history, complications and prognosis |
|
Cystic fibrosis natural history, complications and prognosis in the news |
|
Blogs on Cystic fibrosis natural history, complications and prognosis |
|
Risk calculators and risk factors for Cystic fibrosis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: , Shaghayegh Habibi, M.D.[2]
Overview
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History
Malnutrition and poor growth (due to loss of pancreatic exocrine function) leads to death in the first decade of life for most untreated patients.[1]
Complications
Prognosis
Life expectancy of patients with cystic fibrosis has been increased over past decades because of better symptomatic treatment strategies.[2]
References
- ↑ Cutting GR (2015). "Cystic fibrosis genetics: from molecular understanding to clinical application". Nat. Rev. Genet. 16 (1): 45–56. doi:10.1038/nrg3849. PMC 4364438. PMID 25404111.
- ↑ Ratjen F, Döring G (2003). "Cystic fibrosis". Lancet. 361 (9358): 681–9. doi:10.1016/S0140-6736(03)12567-6. PMID 12606185.